Table 1.
Studies involving the use of mesenchymal stem cells-conditioned medium (MSC-CM).
Pathologies | Donor cells | References |
---|---|---|
Lung injury | BMMSCs | [55] |
Myocardial infarction | ADSCs | [56] |
Cerebral injury/ischemia/stroke | BMMSCs | [57] |
Spinal cord injury | BMMSCs | [58] |
Prevention of muscular degeneration | ADSCs | [59] |
Acute and chronic hind limb ischemia | ADSCs | [60] |
Skin wound healing | ADSCs | [61] |
Colitis | Amniotic fluid | [62] |
Acute liver injury/failure | Amniotic fluid | [63] |
Alzheimer’s disease | DPSCs | [64] |
Bone defects | BMMSCs | [65] |
Osteoarthritis | WJMSCs | [66] |
Corneal epithelial wound healing | hUCESCs | [49] |
Uveitis | hUCESCs | [50] |
Alopecia | ADSCs | [67] |
Liver fibrosis | UCPVCs | [68] |
Parkinson’s disease | WJMSCs | [69] |
Multiple esclerosis | PDLSCs | [70] |
Regeneration of atrophied muscles | UCPVCs | [71] |
Cancer | hUCESCs | [23] |
BMMSCs: Bone marrow-derived mesenchymal stem cells; ADSCs: Adipose-derived stem cells; DPSC: Dental pulp stem cells; WJMSCs: Umbilical cord Wharton's Jelly mesenchymal stem cells; hUCESCs: Human uterine cervical stem cells; UCPVCs: Umbilical cord perivascular cells; PDLSCs: Periodontal ligament stem cells.